Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-23 · accession 0001610717-23-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-25 | 2023-05-23 | TXG | Wilbur James | Chief Commercial Off | S - Sale | $55.07 | -316 | 111.0K | -0.3% | -$17.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-23 | S | D | 316 | $55.07 | 110,952 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. (F2) Includes 874 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 12, 2023. |